Mason Carrico
Stock Analyst at Stephens
(0.75)
# 4,131
Out of 5,076 analysts
60
Total ratings
35.2%
Success rate
-4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACB Pacific Biosciences of California | Maintained: Buy | $2 → $2.5 | $2.06 | +21.36% | 4 | Oct 23, 2026 | |
| CTKB Cytek Biosciences | Maintained: Buy | $4.75 → $6 | $5.43 | +10.50% | 4 | Oct 23, 2026 | |
| TXG 10x Genomics | Downgraded: Hold | $65 | $69.75 | -6.81% | 4 | Oct 23, 2026 | |
| ILMN Illumina | Downgraded: Hold | $110 → $275 | $269.40 | +2.08% | 9 | Oct 23, 2026 | |
| MYGN Myriad Genetics | Rated: Hold | $30 → $3 | $5.76 | -47.92% | 6 | Aug 18, 2026 | |
| GH Guardant Health | Reiterated: Buy | $63 → $195 | $162.94 | +19.68% | 4 | Aug 4, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $32 → $55 | $46.04 | +19.46% | 5 | Aug 4, 2026 | |
| ATEC Alphatec Holdings | Initiated Coverage: Buy | $15 | $11.36 | +32.04% | 1 | Jul 23, 2026 | |
| IRTC iRhythm Holdings | Initiated Coverage: Buy | $160 | $119.64 | +33.73% | 1 | Jul 22, 2026 | |
| ESTA Establishment Labs Holdings | Rated: Buy | $90 | $63.52 | +41.69% | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $145 | $176.69 | -17.94% | 2 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $11 | $16.39 | n/a | 4 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $70 | $20.03 | n/a | 1 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $18 | $69.16 | n/a | 7 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $33.15 | n/a | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $401.37 | n/a | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.1 → $1.25 | $2.84 | n/a | 2 | May 24, 2022 |
Pacific Biosciences of California
Oct 23, 2026
Maintained: Buy
Price Target: $2 → $2.5
Current: $2.06
Upside: +21.36%
Cytek Biosciences
Oct 23, 2026
Maintained: Buy
Price Target: $4.75 → $6
Current: $5.43
Upside: +10.50%
10x Genomics
Oct 23, 2026
Downgraded: Hold
Price Target: $65
Current: $69.75
Upside: -6.81%
Illumina
Oct 23, 2026
Downgraded: Hold
Price Target: $110 → $275
Current: $269.40
Upside: +2.08%
Myriad Genetics
Aug 18, 2026
Rated: Hold
Price Target: $30 → $3
Current: $5.76
Upside: -47.92%
Guardant Health
Aug 4, 2026
Reiterated: Buy
Price Target: $63 → $195
Current: $162.94
Upside: +19.68%
Veracyte
Aug 4, 2026
Reiterated: Buy
Price Target: $32 → $55
Current: $46.04
Upside: +19.46%
Alphatec Holdings
Jul 23, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $11.36
Upside: +32.04%
iRhythm Holdings
Jul 22, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $119.64
Upside: +33.73%
Establishment Labs Holdings
Feb 25, 2026
Rated: Buy
Price Target: $90
Current: $63.52
Upside: +41.69%
Jan 2, 2026
Reiterated: Buy
Price Target: $115 → $145
Current: $176.69
Upside: -17.94%
Sep 2, 2025
Reiterated: Buy
Price Target: $18 → $11
Current: $16.39
Upside: n/a
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $70
Current: $20.03
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $15 → $18
Current: $69.16
Upside: n/a
May 8, 2023
Reiterated: Buy
Price Target: $41
Current: $33.15
Upside: n/a
Dec 16, 2022
Reiterated: Buy
Price Target: n/a
Current: $401.37
Upside: n/a
May 24, 2022
Downgraded: Hold
Price Target: $3.1 → $1.25
Current: $2.84
Upside: n/a